Does Rallies show 13F holders for SIBN?

Yes. Rallies tracks hedge fund and 13F ownership data for SIBN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SIBN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SIBN. It does not provide personalized investment advice.

SIBN (SI-BONE, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

SI-BONE, Inc. Common Stock (SIBN) is a publicly traded Healthcare sector company. As of May 21, 2026, SIBN trades at $14.75 with a market cap of $654.60M and a P/E ratio of -19.64. SIBN moved -0.13% today. Year to date, SIBN is -25.79%; over the trailing twelve months it is -24.81%. Its 52-week range spans $11.48 to $21.89. Analyst consensus is strong buy with an average price target of $22.17. Rallies surfaces SIBN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SIBN stock?

Hedge funds tracked by Rallies that own SIBN include Orbimed Advisors and Bridgewater Associates. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SI-BONE, Inc. Common Stock.

SIBN Key Metrics

Key financial metrics for SIBN
Metric	Value
Price	$14.75
Market Cap	$654.60M
P/E Ratio	-19.64
EPS	$-0.75
Dividend Yield	0.00%
52-Week High	$21.89
52-Week Low	$11.48
Volume	26
Avg Volume	0
Revenue (TTM)	$167.18M
Net Income	$-30.91M
Gross Margin	79.03%

Top Hedge Funds Holding SIBN

Orbimed Advisors holds 2.58M shares of SIBN, changed +0.00% as of Sep 30, 2025.
Bridgewater Associates holds 30.86K shares of SIBN, changed -11.69% as of Jun 30, 2024.

Latest SIBN News

Si-Bone Q4 Loss Narrows to $0.04, Revenue Rises 15% to $56.35M — Feb 24, 2026

Recent SIBN Insider Trades

Maheshwari Anshul sold 2.48K (~$36.44K) on May 18, 2026.
Maheshwari Anshul sold 2.19K (~$32.08K) on May 18, 2026.
DUNN JEFFREY W sold 337 (~$4.43K) on May 4, 2026.

SIBN Analyst Consensus

7 analysts cover SIBN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.17.

Common questions about SIBN

Who owns SIBN stock?: Hedge funds tracked by Rallies that own SIBN include Orbimed Advisors and Bridgewater Associates. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for SI-BONE, Inc. Common Stock.
Does Rallies show 13F holders for SIBN?: Yes. Rallies tracks hedge fund and 13F ownership data for SIBN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SIBN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SIBN. It does not provide personalized investment advice.